lovastatin 75330-75-5 mevinolin Mevacor Altoprev Mevlor Sivlor Altocor MK-803 Monacolin K Lovastatine 6alpha-Methylcompactin Lovastatina Mevinacor Lovastatinum [Latin] 6-alpha-Methylcompactin Lovastatinum MK 803 DTXSID5020784 9LHU78OQFD NSC-758662 (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate L-154803 C10AA02 2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate DTXCID50784 (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate CHEBI:40303 6-Methylcompactin NSC633781 Lovastatinum (Latin) (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-2-Methylbutanoic acid 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester (S)-2-Methylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one 1,2,6,7,8,8a-Hexahydro-beta,delta-dihydroxy-2,6-dimethyl-8-(2-methyl-1-oxobutyoxy)-1-naphthaleneheptanoic acid delta-lactone Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))- 1 alpha-Isomer Lovastatin 6 Methylcompactin (1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-Hydroxy-6-oxooxan-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate MK803 alpha-Isomer Lovastatin, 1 ML-530B Mevinacor 10 Mevinacor 40 ((1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxooxan-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) (2S)-2-methylbutanoate (S)-2-Methylbutyric acid, 8-ester with (4R,6R)-6-[2-[(1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl]ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one Lovastatin, 1 alpha RefChem:5964 (2S)-2-Methylbutanoic Acid, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl Ester (8-(2-(4-hydroxy-6-oxooxan-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) 2-methylbutanoate 616-212-7 ((1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxooxan-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) (2R)-2-methylbutanoate Lovalord Nergadan Artein Lovastatine [French] Lovastatina [Spanish] Lovalip Hipovastin Lovasterol Cholestra Closterol Colevix Hipolip Lestatin Lipivas Lipofren Lovastin Lozutin Paschol Rodatin Rovacor Tecnolip Teroltrat Belvas Lipdip Taucor butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, (2S)- Lovastatin [USAN] MLS000069585 Lovastatin (Standard) 6.alpha.-Methylcompactin MSD 803 MFCD00072164 SMR000058779 (1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate C24H36O5 (S)-(1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2-methylbutanoate HSDB 6534 NCGC00023509-03 Liposcler 6 alpha-Methylcompactin Rextat Monakolin K Lovastatin (Mevacor) (+)-mevinolin (1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (S)-2-methylbutanoate [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate Mevacor (TN) CHEMBL503 Lovastatin & Primycin Lovastatin (USP/INN) SR-05000001880 UNII-9LHU78OQFD Simvastatin EP Impurity E BRN 3631989 Tancor CCRIS 8092 Mevinacor; Lipofren; Nergadan; Mevacor; Lovastatin CRS Monacolin K; 1cqp Lovastatin [USAN:USP:INN:BAN] (2S)-2-METHYLBUTANOIC ACID (1S,3R,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-3,7-DIMETHYL-8-(2-((2R,4R)-TETRAHYDRO-4-HYDROXY-6-OXO-2H-PYRAN-2-YL)ETHYL)-1-NAPHTHALENYL ESTER (2S)-2-Methylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester Butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (2S)- Prestwick_819 CAS-75330-75-5 Mevinolin (lovastatin) LOVASTATIN [MI] LOVASTATIN [INN] Opera_ID_1578 Prestwick0_000516 Prestwick1_000516 Prestwick2_000516 Prestwick3_000516 Spectrum3_001873 Spectrum5_001294 Lovastatin (MK-803) LOVASTATIN [HSDB] LOVASTATIN [VANDF] EC 616-212-7 LOVASTATIN [MART.] SCHEMBL3136 LOVASTATIN [USP-RS] LOVASTATIN [WHO-DD] US9115116, lovastatin BIDD:PXR0113 BSPBio_000471 BSPBio_001265 BSPBio_003346 74133-25-8 cid_53232 MLS001055358 MLS006011867 US9353061, Lovastatina BIDD:GT0749 DivK1c_001032 SPECTRUM1503977 SPBio_002392 BPBio1_000519 GTPL2739 Lovastatin - Bio-X trade mark MEGxm0_000398 orb1309414 orb3139800 LOVASTATIN [ORANGE BOOK] ACon0_000534 ACon1_000390 BDBM34168 HMS503O05 HY-N0504R KBio1_001032 KBio3_002848 LOVASTATIN [EP MONOGRAPH] Simvastatin impurity, lovastatin- NINDS_001032 GLXC-06458 HMS1569H13 HMS1792O07 HMS1923O13 HMS1990O07 HMS2089M06 HMS2093O03 HMS2096H13 HMS2236F07 HMS3039N16 HMS3259F10 HMS3268C03 HMS3403O07 HMS3412H19 HMS3676H19 HMS3713H13 HMS3884B03 LOVASTATIN [USP MONOGRAPH] Pharmakon1600-01503977 ADVICOR COMPONENT LOVASTATIN ALBB-027272 HY-N0504 MK-803; LOVALIP; MEVACOR MSK10235 Tox21_110888 Tox21_201475 Tox21_300268 BBL024473 CCG-39627 EBC-02080 NSC758662 NSC779704 s2061 SBB080686 STK801953 AKOS005267139 Lovastatin for peak identification CRS Lovastatin; Simvastatin EP Impurity E Tox21_110888_1 CS-1990 DB00227 FH24950 KS-1082 Mevinolin from Aspergillus sp., powder NC00713 NSC 758662 NSC-633781 NSC-779704 IDI1_001032 NCGC00023509-04 NCGC00023509-05 NCGC00023509-06 NCGC00023509-07 NCGC00023509-08 NCGC00023509-09 NCGC00023509-10 NCGC00023509-11 NCGC00023509-13 NCGC00023509-14 NCGC00023509-16 NCGC00023509-25 NCGC00254157-01 NCGC00259026-01 AC-13961 BL164644 Butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (2S)- G226 SMR000673570 SBI-0051881.P002 CS-0694830 L0214 NS00000544 SIMVASTATIN IMPURITY E [EP IMPURITY] EN300-52515 C07074 D00359 M02056 AB00052400-17 AB00052400_18 AB00052400_19 Mevinolin from Aspergillus sp., >=98% (HPLC) Q417740 SR-01000000123 SR-01000000123-3 SR-05000001880-1 SR-05000001880-2 BRD-K09416995-001-06-8 BRD-K09416995-001-21-7 BRD-K09416995-001-38-1 BRD-K09416995-001-39-9 BRD-K09416995-001-40-7 Mevacor;Monacolin K;mevinolin;6-alpha-Methylcompactin SIMVASTATIN IMPURITY, LOVASTATIN- [USP IMPURITY] Z754931258 (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-8-(2-((4R,6R)-4-hydroxy-2-oxo-2H-pyran-6-yl)ethyl)-3,7-dimethylnaphtyl(S)-2-methylbutyrat (S)-2-Methyl-butyric acid (1S,3R,7S,8S,8aR)-8-[2-((3R,5R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl ester 1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl 2-methylbutanoate 1S,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate 8-[2-((2R,4R)-4-hydroxy-6-oxo(2H-3,4,5-trihydropyran-2-yl))ethyl](1S,7S,8S,3R, 8aR)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthyl (2S)-2-methylbutanoate Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-- oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))- BUTANOIC ACID, 2-METHYL-, 1,2,3,7,8,8A-HEXAHYDRO-3,7-DIMETHYL-8-(2-(TETRAHYDRO-4-HYDROXY-6-OXO-2H-PYRAN-2-YL)ETHYL)-1-NAPHTHALENYL ESTER, (1S-(1.ALPHA.(R*),3.ALPHA.,7.BETA.,8.BETA.(2S*,4S*),8.ALPHA..BETA.))-
Mostrar todos os 271 sinônimos 
